Revenue Growth

Nature's Path captures the viral Dubai chocolate craze in its new Love Crunch granola, blending social media trends with its organic and philanthropic mission.

As Michigan homeowners face steep premium hikes, a new tech-driven insurer arrives, offering a data-centric model for agents and consumers.

With a fresh Nasdaq listing and battle-tested tech, Duke Robotics is targeting a dual-market breakthrough in civilian and defense drone applications.

Legacy youth organization Camp Fire hires three senior leaders to spearhead its 'Flourish' plan, aiming to reach 250,000 youth across all 50 states.

Profitable and capital-efficient, the HR platform is using its Series B to scale its integrated payroll and finance solution in the US and Europe.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

Neurovascular giant Balt deepens its Irvine roots with a new facility, a $400M investment, and plans for 700 jobs to accelerate stroke-fighting tech.

Diagnostic tool maker TOPDON partners with Amazon for a first-of-its-kind live product showcase during NASCAR, blurring the lines between racing and repair.

Health AI firm Vi secures unicorn status with a $145M deal while launching new AI agents. But can its vision of 'health abundance' overcome ethical hurdles?

Newly independent, auto supplier Versigent will meet investors to prove its critical role in powering the EV and autonomous vehicle revolution.

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

A new Silicon Valley facility will use advanced robots to turn mountains of paper into the high-quality data that artificial intelligence desperately needs.

Three ZenaTech AI drone platforms have entered the final cybersecurity phase for Blue UAS certification, a critical step to accessing the U.S. defense market.

A new partnership embeds specialty drug ordering into clinic software, promising to boost efficiency and patient care in the booming infusion market.

Newly public Yesway faces its first major test with its Q1 earnings. Investors will scrutinize if its aggressive expansion can meet high analyst expectations.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

China's youth-focused video platform Bilibili reports a strong Q1, achieving net profit fueled by a 30% surge in ad revenue and record user engagement.

Hesai Group posts another profitable quarter and a major Mercedes-Benz deal, while unveiling a strategic pivot from hardware to a 'Physical AI' ecosystem.

The second Asian Tourism & Hospitality Awards celebrated industry leaders as new data reveals the region's powerful post-pandemic rebound. See who won.

The Eurasian Development Bank makes its first Uzbekistan investment with a $70M loan to fintech giant Uzum, signaling a major shift in regional development.